Focus Partners Wealth lessened its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 11.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 328,437 shares of the company’s stock after selling 40,639 shares during the quarter. Focus Partners Wealth’s holdings in Cardinal Health were worth $67,224,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Nordea Investment Management AB grew its stake in Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock valued at $133,741,000 after purchasing an additional 494,731 shares in the last quarter. Victory Capital Management Inc. grew its stake in Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after purchasing an additional 707,495 shares in the last quarter. Procyon Advisors LLC grew its stake in Cardinal Health by 78.7% during the 4th quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock valued at $3,499,000 after purchasing an additional 7,499 shares in the last quarter. Public Sector Pension Investment Board grew its stake in Cardinal Health by 66.7% during the 3rd quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock valued at $4,710,000 after purchasing an additional 12,003 shares in the last quarter. Finally, Sierra Summit Advisors LLC acquired a new stake in Cardinal Health during the 3rd quarter valued at approximately $9,897,000. Institutional investors and hedge funds own 87.17% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on CAH. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Monday. Wells Fargo & Company lowered their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Leerink Partners reaffirmed an “outperform” rating and set a $275.00 target price on shares of Cardinal Health in a report on Monday, March 9th. Morgan Stanley increased their target price on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a report on Tuesday, April 28th. Finally, Robert W. Baird set a $248.00 target price on Cardinal Health in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $246.93.
Cardinal Health Stock Up 1.2%
NYSE:CAH opened at $226.52 on Tuesday. The business’s 50 day moving average is $203.46 and its two-hundred day moving average is $208.92. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60. The company has a market cap of $53.05 billion, a PE ratio of 34.64, a P/E/G ratio of 1.22 and a beta of 0.52.
Cardinal Health (NYSE:CAH – Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter last year, the business posted $2.35 EPS. Cardinal Health’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 31.19%.
Cardinal Health Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
